Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


ApaTech announces senior US appointments

3 November 2008

ApaTech, recently recognized for the second successive year as Britain’s fastest growing private medical technology company, announces two senior US appointments.

John Welch joins as VP Marketing from Diomed Inc, a leading manufacturer of surgical, diode based laser systems. As VP Marketing, John was responsible for the introduction and commercialisation of EVLT™ (EndoVenous Laser Treatment) and oversaw significant sales growth and leadership in this rapidly growing market. Prior to Diomed, John was Global VP Marketing for the Surgical Division of Haemonetics Inc. John brings a broad range of sales and marketing experience from within the medical device industry including large organisations such as J&J and CR Bard plus rapid growth emerging technology businesses.

Stephen Koenigsberg joins ApaTech as VP Professional Relations from Stryker Spine where he was Director of Strategic Marketing responsible for surgeon education and corporate professional relations programs. Prior to Stryker Spine, Steve was Director of Marketing at Stryker Biotech responsible for the clinical development and initial global commercialisation of OP-1 (rhBMP-7).

Steve Czick, President of ApaTech Inc, said “both John and Steve bring a wealth of practical marketing and professional relations development experience to ApaTech at a key time in our transition from an early commercial phase to major player in the US orthobiologics market. I am confident that in guiding and supplementing our rapidly growing sales and marketing organizations, they will make a major contribution to ApaTech as we continue to redefine the US orthobiologics market”


Further Information:

+44 20 8731 4640
Simon Cartmell, CEO

+44 20 7796 9999
Robin Hepburn

Notes to Editors:

About ApaTech

ApaTech specialises in producing synthetic bone repair material. It has operations in London, England, Foxborough, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 21 countries around the world.

The Company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the Company’s leadership in applying the science of silicon to bone graft technologies. The Company believes that Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive and osteo-stimulatory activities.

ApaTech is backed by international investors, 3i and Healthcor and was recognized as Britain’s fastest growing medical technology company in both the 2008 and 2007 Sunday Times Fast Track 100 fastest growing private companies review.

More details can be found at

Publisher Contact Information:

ApaTech Ltd
+44 20 8731 4640

Company profile of ApaTech Ltd
Past press releases of ApaTech Ltd.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Dec 6€9.3MSoftware development
Dec 6€1.5MConsumer applications
Dec 6€3.7MInternet commerce
Dec 5€8.0MNanotechnology
Dec 5€11.0MBiotechnology
Dec 5€11.0MRobotics
Dec 5N/ARobotics

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.